These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 11442014)

  • 1. Toxicology studies with recombinant staphylokinase and with SY 161-P5, a polyethylene glycol-derivatized cysteine-substitution mutant.
    Moons L; Vanlinthout I; Roelants I; Moreadith R; Collen D; Rapold HJ
    Toxicol Pathol; 2001; 29(3):285-91. PubMed ID: 11442014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polyethylene glycol-derivatized cysteine-substitution variants of recombinant staphylokinase for single-bolus treatment of acute myocardial infarction.
    Collen D; Sinnaeve P; Demarsin E; Moreau H; De Maeyer M; Jespers L; Laroche Y; Van de Werf F
    Circulation; 2000 Oct; 102(15):1766-72. PubMed ID: 11023930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic and thrombolytic properties of cysteine-linked polyethylene glycol derivatives of staphylokinase.
    Vanwetswinkel S; Plaisance S; Zhi-Yong Z; Vanlinthout I; Brepoels K; Lasters I; Collen D; Jespers L
    Blood; 2000 Feb; 95(3):936-42. PubMed ID: 10648406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant staphylokinase variants with altered immunoreactivity. III: Species variability of antibody binding patterns.
    Collen D; De Cock F; Demarsin E; Jenné S; Lasters I; Laroche Y; Warmerdam P; Jespers L
    Circulation; 1997 Jan; 95(2):455-62. PubMed ID: 9008464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Procoagulant properties of intravenous staphylokinase versus tissue-type plasminogen activator.
    Okada K; Lijnen HR; Moreau H; Vanderschueren S; Collen D
    Thromb Haemost; 1996 Dec; 76(6):857-9. PubMed ID: 8972000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential inhibition with antifibrinolytic agents of staphylokinase and streptokinase induced clot lysis.
    Lijnen HR; Stassen JM; Collen D
    Thromb Haemost; 1995 May; 73(5):845-9. PubMed ID: 7482414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Staphylokinase: fibrinolytic properties and current experience in patients with occlusive arterial thrombosis.
    Collen D; Lijnen HR; Vanderschueren S
    Verh K Acad Geneeskd Belg; 1995; 57(3):183-96; discussion 196-8. PubMed ID: 7483814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative antigenicity of recombinant wild-type staphylokinase (SakSTAR) and a selected mutant (SakSTAR.M38) in a baboon thrombolysis model.
    Vanderschueren S; Stassen JM; Collen D
    J Cardiovasc Pharmacol; 1996 Jun; 27(6):809-15. PubMed ID: 8761847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of site-specific PEGylation on the fibrinolytic activity, immunogenicity, and pharmacokinetics of staphylokinase.
    Liu J; Wang Z; He J; Wang G; Zhang R; Zhao B
    Acta Biochim Biophys Sin (Shanghai); 2014 Sep; 46(9):782-91. PubMed ID: 25098624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of action and thrombolytic potential of staphylokinase.
    Lijnen HR
    Verh K Acad Geneeskd Belg; 1995; 57(4):303-14. PubMed ID: 8571666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical development of PEGylated recombinant staphylokinase (PEG-Sak) for bolus thrombolytic treatment of patients with acute myocardial infarction.
    Moreadith RW; Collen D
    Adv Drug Deliv Rev; 2003 Sep; 55(10):1337-45. PubMed ID: 14499711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New developments in thrombolytic therapy.
    Collen D; Gold HK
    Adv Exp Med Biol; 1990; 281():333-54. PubMed ID: 2129372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonclinical Safety Assessment of a Long-Acting Recombinant PEGylated Factor Eight (BAY 94-9027) With a 60 kDa PEG.
    Ivens IA; Banczyk D; Gutberlet K; Jackman S; Vauléon S; Frisk AL
    Toxicol Pathol; 2019 Jul; 47(5):585-597. PubMed ID: 31132933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant staphylokinase variants with altered immunoreactivity. I: Construction and characterization.
    Collen D; Bernaerts R; Declerck P; De Cock F; Demarsin E; Jenné S; Laroche Y; Lijnen HR; Silence K; Verstreken M
    Circulation; 1996 Jul; 94(2):197-206. PubMed ID: 8674179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Thrombolysis by staphylokinase in rabbits with experimental pulmonary embolus].
    Liu X; Tang Z; Liang X; Ma X; Chen W
    Yao Xue Xue Bao; 1998 Nov; 33(11):801-6. PubMed ID: 12016937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant staphylokinase variants with altered immunoreactivity. IV: Identification of variants with reduced antibody induction but intact potency.
    Collen D; Stockx L; Lacroix H; Suy R; Vanderschueren S
    Circulation; 1997 Jan; 95(2):463-72. PubMed ID: 9008465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Collaborative Angiographic Patency Trial Of Recombinant Staphylokinase (CAPTORS II).
    Armstrong PW; Burton J; Pakola S; Molhoek PG; Betriu A; Tendera M; Bode C; Adgey AA; Bar F; Vahanian A; Van de Werf F;
    Am Heart J; 2003 Sep; 146(3):484-8. PubMed ID: 12947367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Staphylokinase--a specific plasminogen activator].
    Rozpończyk E; Szemraj J; Malinowski M; Rozpończyk J
    Postepy Biochem; 2006; 52(1):80-6. PubMed ID: 16869305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative fibrinolytic properties of staphylokinase and streptokinase in animal models of venous thrombosis.
    Lijnen HR; Stassen JM; Vanlinthout I; Fukao H; Okada K; Matsuo O; Collen D
    Thromb Haemost; 1991 Oct; 66(4):468-73. PubMed ID: 1796398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monitoring manufacturing process yields, purity and stability of structural variants of PEGylated staphylokinase mutant SY161 by quantitative reverse-phase chromatography.
    Johnson C; Royal M; Moreadith R; Bedu-Addo F; Advant S; Wan M; Conn G
    Biomed Chromatogr; 2003 Jul; 17(5):335-44. PubMed ID: 12884399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.